Call Our Office Now:
800-388-3905
800-388-3905
Monthly Archives: February 2013
Plaintiff’s Steering Committee for Stryker Hip Implant Litigation
FOR IMMEDIATE RELEASE Searcy Denney Scarola Barnhart & Shipley Attorney Appointed to Plaintiff’s Steering Committee for Stryker Hip Implant Litigation West Palm Beach, Fla. – (February 26, 2013) – South Florida law firm Searcy Denney Scarola Barnhart & Shipley PA (Searcy Denney) announced today that C. Calvin Warriner, a shareholder at the…
Monthly Archives: February 2013
Stryker Rejuvenate or ABG II failure – The Revision Surgery Dilemma
Now that many victims in whom Stryker’s Rejuvenate or ABG II hip implants were placed have been notified the devices have been recalled they face the very difficult decision about what to do. They now know a defective and recalled medical device is inside them. Some have symptoms, some don’t. Many have been to their…
Monthly Archives: February 2013
Stryker Accolade TMZF Analysis
The Stryker Accolade® TMZF femoral stem was approved by the Food & Drug Administration in 2000, through a process called the 510(k) approval process. This is the method used by manufacturers to get a rapid approval for medical devices to be used inside patients. The 510(k) process allows the device manufacturer to file papers with…
Monthly Archives: February 2013
FDA MAUDE Database — Stryker Accolade TMZF Performance
The Food & Drug Administration has a database called “MAUDE”; which stands for Manufacturer and User Facility Device Experience. MAUDE is the database where physicians, hospitals, researchers and, sometimes even manufacturers, report adverse events involving medical devices. We have researched the MAUDE database to find information relating to Stryker® Accolade TMZF femoral hip implant stem….
Monthly Archives: February 2013
New Jersey Supreme Court Consolidates All Stryker Rejuvenate Cases to Bergen County, New Jersey
On January 24, 2013 the New Jersey Supreme Court issued an order establishing Multi-County Jurisdiction for all Stryker Rejuvenate and ABG II implant cases in Bergen County, New Jersey. Both of these Stryker hip implant systems were voluntarily recalled in July 2012. In August 2012, Searcy Denney filed the first Rejuvenate case in the country…
Monthly Archives: February 2013
Stryker Fourth Quarter Disappointing, Takes $133 Million to Cover Rejuvenate Recall Expenses
Stryker Corp. of Kalamazoo, Michigan recently released information regarding the fourth quarter 2012 financial fallout resulting from its recall of the Rejuvenate hip implant. Earnings fell 33 percent or .71 per share to $270 million from $401 million or $1.05 a share. When Stryker voluntarily recalled its Rejuvenate and ABG II modular-neck hip stems in…
-
Categories
RSS
Archives
Videos
Watch videos on what you need to know
Dangerous Stryker Rejuvenate Hip Replacement is Recalled
How To Figure Out What Type Of Implant You Have...
